Hidden Obesity in Dialysis Patients

Clinical Implications

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

While body-mass index (BMI) is used to diagnose obesity in the general population, its application in the end-stage renal disease (ESRD) population is fraught with difficulty. A major limitation is its inability to distinguish muscle mass from fat mass, thereby leading to misclassification of individuals with poor muscle mass but excess adipose tissue as non-obese (i.e. BMI <30 kg/m2). As muscle wasting is common among ESRD patients, this is an important problem. A substantial proportion of ESRD patients have levels of BMI in the normal range, yet excess adiposity based on other measures. The importance of this “hidden” obesity remains to be determined, but it must be recognized in order for obesity interventions to be appropriately targeted and tested in the ESRD population.

Original languageEnglish (US)
Pages (from-to)391-395
Number of pages5
JournalSeminars in Dialysis
Volume29
Issue number5
DOIs
StatePublished - Sep 1 2016

Fingerprint

Chronic Kidney Failure
Dialysis
Obesity
Body Mass Index
Muscles
Population
Adiposity
Adipose Tissue
Reference Values
Fats

ASJC Scopus subject areas

  • Nephrology

Cite this

Hidden Obesity in Dialysis Patients : Clinical Implications. / Abramowitz, Matthew K.; Sharma, Deep; Folkert, Vaughn Wesley.

In: Seminars in Dialysis, Vol. 29, No. 5, 01.09.2016, p. 391-395.

Research output: Contribution to journalReview article

@article{ceade42d8fc7491cb349b7f3a52b38b2,
title = "Hidden Obesity in Dialysis Patients: Clinical Implications",
abstract = "While body-mass index (BMI) is used to diagnose obesity in the general population, its application in the end-stage renal disease (ESRD) population is fraught with difficulty. A major limitation is its inability to distinguish muscle mass from fat mass, thereby leading to misclassification of individuals with poor muscle mass but excess adipose tissue as non-obese (i.e. BMI <30 kg/m2). As muscle wasting is common among ESRD patients, this is an important problem. A substantial proportion of ESRD patients have levels of BMI in the normal range, yet excess adiposity based on other measures. The importance of this “hidden” obesity remains to be determined, but it must be recognized in order for obesity interventions to be appropriately targeted and tested in the ESRD population.",
author = "Abramowitz, {Matthew K.} and Deep Sharma and Folkert, {Vaughn Wesley}",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/sdi.12516",
language = "English (US)",
volume = "29",
pages = "391--395",
journal = "Seminars in Dialysis",
issn = "0894-0959",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Hidden Obesity in Dialysis Patients

T2 - Clinical Implications

AU - Abramowitz, Matthew K.

AU - Sharma, Deep

AU - Folkert, Vaughn Wesley

PY - 2016/9/1

Y1 - 2016/9/1

N2 - While body-mass index (BMI) is used to diagnose obesity in the general population, its application in the end-stage renal disease (ESRD) population is fraught with difficulty. A major limitation is its inability to distinguish muscle mass from fat mass, thereby leading to misclassification of individuals with poor muscle mass but excess adipose tissue as non-obese (i.e. BMI <30 kg/m2). As muscle wasting is common among ESRD patients, this is an important problem. A substantial proportion of ESRD patients have levels of BMI in the normal range, yet excess adiposity based on other measures. The importance of this “hidden” obesity remains to be determined, but it must be recognized in order for obesity interventions to be appropriately targeted and tested in the ESRD population.

AB - While body-mass index (BMI) is used to diagnose obesity in the general population, its application in the end-stage renal disease (ESRD) population is fraught with difficulty. A major limitation is its inability to distinguish muscle mass from fat mass, thereby leading to misclassification of individuals with poor muscle mass but excess adipose tissue as non-obese (i.e. BMI <30 kg/m2). As muscle wasting is common among ESRD patients, this is an important problem. A substantial proportion of ESRD patients have levels of BMI in the normal range, yet excess adiposity based on other measures. The importance of this “hidden” obesity remains to be determined, but it must be recognized in order for obesity interventions to be appropriately targeted and tested in the ESRD population.

UR - http://www.scopus.com/inward/record.url?scp=85028270784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028270784&partnerID=8YFLogxK

U2 - 10.1111/sdi.12516

DO - 10.1111/sdi.12516

M3 - Review article

VL - 29

SP - 391

EP - 395

JO - Seminars in Dialysis

JF - Seminars in Dialysis

SN - 0894-0959

IS - 5

ER -